5caq: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==EGFR kinase domain mutant "TMLR" with compound 33== | ==EGFR kinase domain mutant "TMLR" with compound 33== | ||
<StructureSection load='5caq' size='340' side='right' caption='[[5caq]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='5caq' size='340' side='right' caption='[[5caq]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4ZJ:N-[2-[(3R,4S)-3-FLUORANYL-4-METHOXY-PIPERIDIN-1-YL]PYRIMIDIN-4-YL]-2-METHYL-1-PROPAN-2-YL-IMIDAZO[4,5-C]PYRIDIN-6-AMINE'>4ZJ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4ZJ:N-[2-[(3R,4S)-3-FLUORANYL-4-METHOXY-PIPERIDIN-1-YL]PYRIMIDIN-4-YL]-2-METHYL-1-PROPAN-2-YL-IMIDAZO[4,5-C]PYRIDIN-6-AMINE'>4ZJ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5caq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5caq OCA], [http://pdbe.org/5caq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5caq RCSB], [http://www.ebi.ac.uk/pdbsum/5caq PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5caq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5caq OCA], [http://pdbe.org/5caq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5caq RCSB], [http://www.ebi.ac.uk/pdbsum/5caq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5caq ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 20: | Line 21: | ||
</div> | </div> | ||
<div class="pdbe-citations 5caq" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5caq" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Epidermal Growth Factor Receptor|Epidermal Growth Factor Receptor]] | |||
== References == | == References == | ||
<references/> | <references/> | ||